KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Goodwill (2016 - 2025)

Historic Goodwill for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $8.3 billion.

  • Gilead Sciences' Goodwill changed 0.0% to $8.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $8.3 billion for FY2024, which is 0.0% changed from last year.
  • Per Gilead Sciences' latest filing, its Goodwill stood at $8.3 billion for Q3 2025, which was down 0.0% from $8.3 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Goodwill ranged from a high of $8.3 billion in Q1 2021 and a low of $8.3 billion during Q1 2022
  • Its 5-year average for Goodwill is $8.3 billion, with a median of $8.3 billion in 2022.
  • Per our database at Business Quant, Gilead Sciences' Goodwill soared by 10242.9% in 2021 and then fell by 24.0% in 2022.
  • Over the past 5 years, Gilead Sciences' Goodwill (Quarter) stood at $8.3 billion in 2021, then decreased by 0.22% to $8.3 billion in 2022, then changed by 0.0% to $8.3 billion in 2023, then changed by 0.0% to $8.3 billion in 2024, then changed by 0.0% to $8.3 billion in 2025.
  • Its Goodwill stands at $8.3 billion for Q3 2025, versus $8.3 billion for Q2 2025 and $8.3 billion for Q1 2025.